Developing an Intervention to Prevent Visceral Adipose Tissue Accumulation
NCT ID: NCT01778712
Last Updated: 2016-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
71 participants
INTERVENTIONAL
2012-04-30
2016-02-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of a Technology-based System and an In-person Behavioral Weight Loss Intervention in the Severely Obese
NCT01537796
Diet, Exercise, Metabolism, and Obesity in Older Women
NCT00664729
Fitbit / Healthy Weight Management Study
NCT02381262
Onsite vs. Virtual Group Fitness in Overweight/Obese Women
NCT04974476
Obesity Prevention After Smoking Cessation in Menopause
NCT00064961
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Intervention
Multi-level intervention
Multi-level intervention
The development of a lifestyle program intended to intervene on the individual, social network and community over two years
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Multi-level intervention
The development of a lifestyle program intended to intervene on the individual, social network and community over two years
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Female
* African American or Caucasian
* Age 42 years or older
* Intact uterus, at least one functioning ovary, at least one menstrual period in the last 12 months prior to screening.
* Sufficient motivation level to make lifestyle changes, as determined by WISHFIT staff.
Exclusion Criteria
* Physical activity \> 90 min per week
* Metabolic conditions or use of medications that affect weight of visceral adipose tissue (diabetes, acquired immune deficiency syndrome, weight \> 300 lbs)
* Presence or history of major psychiatric comorbidity (i.e. dementia, schizophrenia, bipolar disorder, alcohol/drug addiction) in the last 6 months
* History of inpatient mental health treatment
* Currently prescribed antipsychotic medication
* History of hallucinations or bizarre thoughts
* Current pregnancy
* Has been told by a physician that it is unsafe to engage in physical activity
* An illness expected to limit functional status or life expectancy, including: heart failure, recent heart attack, liver cirrhosis, kidney failure, oncologic conditions, history or heart surgery, angioplasty or artery stenting.
42 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Heart, Lung, and Blood Institute (NHLBI)
NIH
Rush University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lynda Powell, PhD, MEd
PhD, MEd
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Lynda H. Powell, PhD, MEd
Role: PRINCIPAL_INVESTIGATOR
Rush University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Preventive Medicine, Rush University Medical Center
Chicago, Illinois, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09090108
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.